[AML in Adults - An Update on Diagnosis, Risk Classification and Therapy].

Abstract excerpt

There are several changes in the revised WHO classification for acute leukemia. The latest version of the European Leukemia Network (ELN)-risk classification defines AML with mutations in RUNX1, ASXL1 or TP53 to fall in the unfavorable risk group. Consequently, the somatic molecular genetic testing at the time of initial diagnosis should encompass these before mentioned three genes next to the already routine...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to ASXL1 gene
• Share to ELN gene
• Share to Leukemia, Myeloid, Acute